During fires, the effects of heat and noxious effluents are cumulative in causing injury to the victims. Carbon monoxide (CO), which is invariably present as a toxic component of fire emissions, often acts synergistically with cyanide released by various materials. Clinical findings are variable, depending on the extent of external burns, upper airway and lung damage, and toxic exposure. Neuropsychiatrie symptoms and respiratory distress are common manifestations. Life-threatening complications, such as pulmonary oedema, may suddenly develop up to several days after the smoke exposure. Therapeutic measures include general supportive care as well as the treatment of bums and associated systemic toxicity. Arterial blood gases, carboxyhaemoglobin and cyanide levels should be monitored. Patients exposed to significant concentrations of CO require hyperbaric oxygen therapy. Suspected cyanide poisoning must be treated without the waiting for laboratory confirmation. Untimely or incorrect intervention may compromise the chances of survival and seriously affect the future health status of fire victims.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.